| | english | español | français |
Go to record ID

  Home|Finding Information|Record details   Printer-friendly version

Information Resource
Record information and status
Record ID
Date of creation
2012-05-11 15:28 UTC (dina.abdelhakim@cbd.int)
Date of publication
2012-05-11 15:28 UTC (dina.abdelhakim@cbd.int)

General Information
Deployment of innovative genetic vector control strategies: Progress on regulatory and biosafety aspects, capacity building and development of best-practice guidance
Camilla J. Beech, S.S. Vasan, M. Megan Quinlan, Margareth Lara Capurro, Luke Alphey, Vicente Bayard, Madama Bouaré, Maria Corena McLeod, Pattamaporn Kittayapong, James V. Lavery, Lee Han Lim, Mauro Toledo Marrelli, J. Nagaraju, Kenneth Ombongi, Rofina Yasmin Othman, Vilasini Pillai, Janine Ramsey, Rachel Reuben, Robert I. Rose, Brij Kishore Tyagi, and John Mumford
Author’s contact information
John Mumford

Imperial College London, Centre for Environmental Policy,
Silwood Campus, Ascot SL5 7PY, UK

email: j.mumford@imperial.ac.uk
  • English
Publication date
Summary, abstract or table of contents
In the ongoing fight against vectors of human diseases, disease endemic countries (DECs) may soon benefit from innovative control strategies involving modified insect vectors. For instance, three promising methods (viz. RIDL® [Release of Insects with a Dominant Lethal], Wolbachia infection, and refractory mosquito technology) are being developed by researchers around the world to combat Aedes aegypti, the primary mosquito vector of viral fevers such as dengue (serotypes 1-4), chikungunya and yellow fever. Some of these techniques are already being extended to other vectors such as Aedes albopictus (the secondary vector of these diseases) and Anopheles mosquito species that transmit malaria. To enable DECs to take advantage of these promising methods, initiatives are underway that relate to biosafety, risk assessment and management, and ethical-social-cultural (ESC) aspects to consider prior to and during the possible deployment of these technologies as part of an integrated vector control programme. This is a brief overview of the objectives and timelines of some of the initiatives being championed by international institutions, including the United Nations Development Programme (UNDP), the World Health Organization (WHO) and the Grand Challenges in Global Health (GCGH) initiative co-sponsored by the Bill & Melinda Gates Foundation.
Thematic areas
  • Scientific and technical issues
    • Risk assessment
Background material to the “Guidance on risk assessment of living modified organisms”
Is this document is recommend as background material for the “Guidance on Risk Assessment of Living Modified Organisms”
Section(s) of the “Guidance on Risk Assessment of Living Modified Organisms” this background material is relevant
  • 5. Risk assessment of living modified mosquitoes species that act as vectors of human and animal diseases
Additional Information
Type of resource
  • Article (journal / magazine / newspaper)
11 page PDF
Asia Pacific Journal of Molecular Biology and Biotechnology
Keywords and any other relevant information
Keywords: Biosafety, Capacity building, Genetic Modification, Guidance, Insects, Regulation.

Citation: AsPac J. Mol. Biol. Biotechnol. Vol. 17 (3), 2009